Business Monitor International, Nov 2009, Pages: 60
for the Q110 update of the BangladeshPharmaceuticals & Healthcarereport. The main drivers of medicine sales in Bangladesh are: increased government involvement in healthcare; a greater prevalence of chronic
Business Monitor International, June 2011, Pages: 88
BangladeshPharmaceuticals and HealthcareReport provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies
Business Monitor International, July 2010, Pages: 43
.7 out of 100 on BMI's Pharmaceuticals & Healthcare BERs for Q310. This makes it the region’s 14th most attractive market, behind Vietnam (42.1) and ahead of Bangladesh (39.7). Sri Lanka scores above
Business Monitor International, Dec 2009, Pages: 83
Pharmaceutical (SAJA)
- TABUK Pharmaceutical Manufacturing
- Al Jazeera Pharmaceutical Industries (JPI) Saudi Arabia Pharmaceuticals and HealthcareReportQ1 2010
Business Monitor International, April 2008, Pages: 62
Pharmaceutical Manufacturers (APM)
- Dar Al Dawa (DAD)
- Hikma Pharmaceuticals
- Jordanian Pharmaceutical Manufacturing (JPM) Jordan Pharmaceuticals and HealthcareReportQ2 2008
Business Monitor International, Feb 2009, Pages: 75
-Bader Sultan & Bros
-Safwan Trading And Contracting Company Kuwait Pharmaceuticals and HealthcareReportQ1 2009
Business Monitor International, April 2009, Pages: 79
Pharmaceutical Joint Stock Company (Ampharco)
- Vidipha Central Pharmaceutical Joint Stock Company Vietnam Pharmaceuticals and HealthcareReportQ2 2009
Business Monitor International, Feb 2009, Pages: 101
Products (APP)
- Prime Pharmaceutical
- Bumimedic
- Hovid
- Chemical Company of Malaysia (CCM)
- Kotra Pharma
- YSP Southeast Holding Malaysia Pharmaceuticals and HealthcareReportQ1 2009
Business Monitor International, Jan 2008, Pages: 64
- Sanofi-Aventis
- United Pharmaceutical Manufacturers Jordan Pharmaceuticals and HealthcareReportQ1 2008
Global Industry Analysts, Inc., Oct 2006, Pages: 496
$
million) IV-41
Table 109: Annual Sales Analysis by Quarter: 2005-2006
(In US$ million) IV-42
Barr Laboratories, Inc. (USA) IV-48
Duramed Pharmaceutical, Inc. (USA) IV-51
15. Bayer HealthCare AG
Global Industry Analysts, Inc., Oct 2006, Pages: 699
Valeant Pharmaceuticals to Develop Viramidine(R) II-68
Biota Discovers a New Group of Antiviral Drugs against RSV II-68
Serum Launches Q-Vac, a Combination Vaccine II-68
Chongqing Jiachen to Produce
ICON Group International, Jan 2011, Pages: 329
participating in this industry include Collegium Pharmaceutical, McNeil Consumer Healthcare, Meda Pharmaceuticals, Novartis Consumer Healthcare, and Schering-Plough Corporation. In addition to the sources
ICON Group International, Jan 2011, Pages: 329
in this industry include Abbott Laboratories, Astellas Pharma, Bayer HealthCare AG, Bristol-Myers Squibb Co., and Cubist Pharmaceuticals. In addition to the sources indicated below, additional information available
ICON Group International, Jan 2011, Pages: 329
participating in this industry include Abbott Laboratories, Alcon Pharmaceuticals, Astellas Pharma, AstraZeneca, and Bayer HealthCare AG. In addition to the sources indicated below, additional information
